These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 8375123)

  • 21. Pharmacokinetic modelling of morphine, morphine-3-glucuronide and morphine-6-glucuronide in plasma and cerebrospinal fluid of neurosurgical patients after short-term infusion of morphine.
    Meineke I; Freudenthaler S; Hofmann U; Schaeffeler E; Mikus G; Schwab M; Prange HW; Gleiter CH; Brockmöller J
    Br J Clin Pharmacol; 2002 Dec; 54(6):592-603. PubMed ID: 12492606
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Morphine-3-glucuronide inhibits morphine induced, but enhances morphine-6-glucuronide induced locomotor activity in mice.
    Handal M; Ripel A; Aasmundstad T; Skurtveit S; Mørland J
    Pharmacol Biochem Behav; 2007 Mar; 86(3):576-86. PubMed ID: 17343905
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Oral morphine in cancer pain: influences on morphine and metabolite concentration.
    McQuay HJ; Carroll D; Faura CC; Gavaghan DJ; Hand CW; Moore RA
    Clin Pharmacol Ther; 1990 Sep; 48(3):236-44. PubMed ID: 2401122
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Plasma morphine and glucuronide (M3G and M6G) concentrations in hospice inpatients.
    Ashby M; Fleming B; Wood M; Somogyi A
    J Pain Symptom Manage; 1997 Sep; 14(3):157-67. PubMed ID: 9291702
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High levels of morphine-6-glucuronide in street heroin addicts.
    Antonilli L; Semeraro F; Suriano C; Signore L; Nencini P
    Psychopharmacology (Berl); 2003 Nov; 170(2):200-4. PubMed ID: 12774191
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Plasma concentrations and renal clearance of morphine, morphine-3-glucuronide and morphine-6-glucuronide in cancer patients receiving morphine.
    Somogyi AA; Nation RL; Olweny C; Tsirgiotis P; van Crugten J; Milne RW; Cleary JF; Danz C; Bochner F
    Clin Pharmacokinet; 1993 May; 24(5):413-20. PubMed ID: 8504624
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Population pharmacokinetics of morphine and morphine-6-glucuronide following rectal administration--a dose escalation study.
    Brokjær A; Kreilgaard M; Olesen AE; Simonsson US; Christrup LL; Dahan A; Drewes AM
    Eur J Pharm Sci; 2015 Feb; 68():78-86. PubMed ID: 25486331
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Disposition of morphine and its 3- and 6-glucuronide metabolites during morphine infusion in the sheep.
    Milne RW; Sloan PA; McLean CF; Mather LE; Nation RL; Runciman WB; Rutten AJ; Somogyi AA
    Drug Metab Dispos; 1993; 21(6):1151-6. PubMed ID: 7905398
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Plasma concentrations of morphine, morphine-3-glucuronide, and morphine-6-glucuronide after intravenous and oral administration to healthy volunteers: relationship to nonanalgesic actions.
    Westerling D; Persson C; Höglund P
    Ther Drug Monit; 1995 Jun; 17(3):287-301. PubMed ID: 7624926
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of the disposition of hepatically-generated morphine-3-glucuronide and morphine-6-glucuronide in isolated perfused liver from the guinea pig.
    Milne RW; Jensen RH; Larsen C; Evans AM; Nation RL
    Pharm Res; 1997 Aug; 14(8):1014-8. PubMed ID: 9279882
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacokinetic differences of morphine and morphine-glucuronides are reflected in locomotor activity.
    Handal M; Grung M; Skurtveit S; Ripel A; Mørland J
    Pharmacol Biochem Behav; 2002 Nov; 73(4):883-92. PubMed ID: 12213535
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Plasma morphine-3-glucuronide, morphine-6-glucuronide and morphine concentrations in patients receiving long-term epidural morphine.
    Schneider JJ; Ravenscroft PJ; Cavenagh JD; Brown AM; Bradley JP
    Br J Clin Pharmacol; 1992 Nov; 34(5):431-3. PubMed ID: 1467139
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacokinetic modeling of M6G formation after oral administration of morphine in healthy volunteers.
    Lötsch J; Weiss M; Ahne G; Kobal G; Geisslinger G
    Anesthesiology; 1999 Apr; 90(4):1026-38. PubMed ID: 10201674
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Relative bioavailability of controlled release morphine tablets (MST continus) in cancer patients.
    Poulain P; Hoskin PJ; Hanks GW; A-Omar O; Walker VA; Johnston A; Turner P; Aherne GW
    Br J Anaesth; 1988 Nov; 61(5):569-74. PubMed ID: 3207527
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Morphine, morphine-6-glucuronide and morphine-3-glucuronide pharmacokinetics in newborn infants receiving diamorphine infusions.
    Barrett DA; Barker DP; Rutter N; Pawula M; Shaw PN
    Br J Clin Pharmacol; 1996 Jun; 41(6):531-7. PubMed ID: 8799518
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacokinetics of morphine-6-glucuronide following oral administration in healthy volunteers.
    Villesen HH; Kristensen K; Hansen SH; Jensen NH; Skram U; Christrup LL
    Eur J Clin Pharmacol; 2007 Aug; 63(8):761-7. PubMed ID: 17541571
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bioavailability of a morphine suppository is increased after intracolostomal administration in colostoma-constructed rabbits.
    Nagasawa K; Kintsuji S; Nakanishi H; Nagai K; Fujimoto S
    Int J Pharm; 2003 Oct; 265(1-2):65-73. PubMed ID: 14522119
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of a differential radioimmunoassay technique for the determination of morphine and morphine-6-glucuronide in human plasma.
    Chapman DJ; Joel SP; Aherne GW
    J Pharm Biomed Anal; 1994 Mar; 12(3):353-60. PubMed ID: 8031935
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Start of oral morphine to cancer patients: effective serum morphine concentrations and contribution from morphine-6-glucuronide to the analgesia produced by morphine.
    Klepstad P; Kaasa S; Borchgrevink PC
    Eur J Clin Pharmacol; 2000 Jan; 55(10):713-9. PubMed ID: 10663448
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Morphine glucuronide-to-morphine plasma ratios are unaffected by the UGT2B7 H268Y and UGT1A1*28 polymorphisms in cancer patients on chronic morphine therapy.
    Holthe M; Klepstad P; Zahlsen K; Borchgrevink PC; Hagen L; Dale O; Kaasa S; Krokan HE; Skorpen F
    Eur J Clin Pharmacol; 2002 Aug; 58(5):353-6. PubMed ID: 12185559
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.